By Fineline Cube 
Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease, has reportedly secured close to RMB 100 million (USD 13.7 million) through a Series A++ financing round. The sole backer was the Beijing Medical and Health Industry Investment Fund. The funds will be allocated to intensify research and development of innovative devices for coronary heart disease diagnosis and treatment, as well as pulsatile left ventricular assist system products. Additionally, the company plans to boost market promotion for its approved cardiac stabilizers and other products.
Company Background
Founded in 2021, Yuewei Medtech has established a strong presence in China’s medical device sector. The company is recognized for its portfolio of leading products, which include next-generation cardiac stabilizers, a vascular anastomosis quality control system, and a coronary heart disease scoring system.
Funding Utilization
The proceeds from this financing round will be strategically used to advance the development of novel medical devices aimed at improving diagnostic accuracy and treatment outcomes for coronary heart disease. Furthermore, the company is committed to enhancing its market reach by promoting its existing product line, which has already gained significant traction in the domestic market.-Fineline Info & Tech